abstract |
Disclosed is an antagonist of microRNA (miRNA-29) expression and / or function for use in the prevention and / or treatment of aortic aneurysms, particularly abdominal aortic aneurysms (AAA). A method for identifying an miRNA-29 antagonist, a pharmaceutical composition comprising the miRNA-29 antagonist, and a method for preventing and treating age-related aortic aneurysm formation in a subject in need of such treatment. [Selection figure] None |